TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17653742

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine (100 mg)
Number of subjects: 52

Group type: COMPARATOR
Intervention: 0.125% bupivacaine (50 mg)
Number of subjects: 52
Study: 16297755

Group type: EXPERIMENTAL
Intervention: 40% N2O in O2 via facemask
Number of subjects: 60

Group type: COMPARATOR
Intervention: 100% O2 via facemask
Number of subjects: 60
Study: 11932297

Group type: EXPERIMENTAL
Intervention: GH (0.06 mg/kg.d)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GH (0.03 mg/kg.d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9704789

Group type: EXPERIMENTAL
Intervention: Reverse transcriptase‐polymerase chain reaction
Number of subjects: 35

Group type: COMPARATOR
Intervention: Genomic‐polymerase chain reaction
Number of subjects: 35
Study: 8554838

Group type: EXPERIMENTAL
Intervention: Progesterone pessaries (400 mg twice a day)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 30573480

Group type: EXPERIMENTAL
Intervention: Combination therapy with an ACE inhibitor (perindopril) and a beta-blocker (bisoprolol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27683297

Group type: EXPERIMENTAL
Intervention: Immediate aggressive physiotherapy (Group A)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Delayed aggressive physiotherapy (Group B)
Number of subjects: 220
Study: 26646251

Group type: EXPERIMENTAL
Intervention: 2-day training intervention 'Older People's Shoes' for healthcare assistants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training as usual (Control)
Number of subjects: 0
Study: 23620421

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 56

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 56
Study: 21063906

Group type: COMPARATOR
Intervention: Corn gluten meal (CGM) at 200 g kg⁻¹
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corn gluten meal (CGM) at 100 g kg⁻¹
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corn gluten meal (CGM) at varying concentrations (0 to 200 g kg⁻¹)
Number of subjects: 0
Study: 18578300

Group type: EXPERIMENTAL
Intervention: Activity-based cognitive fear reduction (ABCF) procedure
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 266
Study: 16492915

Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 12646971

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (10 mg/kg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 17
Study: 10883413

Group type: COMPARATOR
Intervention: IVIG
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IVIG-N
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IVIG-L
Number of subjects: 30
Study: 9179659

Group type: EXPERIMENTAL
Intervention: UFT adjuvant therapy (1:4 mixture of tegafur and uracil)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Nonadjuvant therapy
Number of subjects: 66
Study: 1490666

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH) alone, 2.6 IU/m2 body surface area daily
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Combination treatment with rhGH (2.6 IU/m2 daily) and oxandrolone (0.1 mg/kg body weight orally)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH) alone, increased dose to 3.4 IU/m2 daily
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Combination treatment with rhGH (3.4 IU/m2 daily) and reduced oxandrolone (0.05 mg/kg daily)
Number of subjects: 91
Study: 3966331

Group type: EXPERIMENTAL
Intervention: 1 mg/kg flecainide
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 2 mg/kg flecainide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Flecainide diluent
Number of subjects: 22
Study: 30545337

Group type: EXPERIMENTAL
Intervention: Paediatric dentists (PDs)
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Paediatric dentists (PDs) aged 40 years or younger
Number of subjects: 588

Group type: COMPARATOR
Intervention: General dental practitioners (GDPs)
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: General dental practitioners (GDPs) and paediatric dentists (PDs)
Number of subjects: 588
Study: 28322235

Group type: EXPERIMENTAL
Intervention: Tryptophan Depletion (TD)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Estradiol treatment
Number of subjects: 33
Study: 26604001

Group type: EXPERIMENTAL
Intervention: Thinking Healthy Programme Peer-delivered (THPP) - 10 individual and 4 group sessions in Pakistan or 6-14 individual sessions in India
Number of subjects: 840

Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Thinking Healthy Programme Peer-delivered (THPP)
Number of subjects: 840
Study: 24075274

Group type: EXPERIMENTAL
Intervention: CUSA with a bipolar sealer (Aquamantys 2.3 Bipolar Sealer); n = 55
Number of subjects: 109

Group type: COMPARATOR
Intervention: CUSA with standard bipolar cautery (BC); n = 54
Number of subjects: 109
Study: 21163550

Group type: EXPERIMENTAL
Intervention: Education plus biometric feedback
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education plus biometric feedback and dermatologist skin examination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Education only
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Education plus dermatologist skin examination
Number of subjects: 0
Study: 18331935

Group type: EXPERIMENTAL
Intervention: Mandibular cervical headgear (MCH) therapy followed by fixed appliances
Number of subjects: 21

Group type: COMPARATOR
Intervention: Untreated Class III controls
Number of subjects: 21
Study: 16641265

Group type: EXPERIMENTAL
Intervention: 2x pTHr.HIVA followed by 1x MVA.HIVA
Number of subjects: 32

Group type: COMPARATOR
Intervention: 2x MVA.HIVA
Number of subjects: 32

Group type: COMPARATOR
Intervention: 3x placebo
Number of subjects: 32
Study: 14703955

Group type: EXPERIMENTAL
Intervention: FTY (0.25 - 3.5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FTY (3.5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FTY
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FTY (10 microM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FTY (0.1 microM)
Number of subjects: 0
Study: 11109298

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Circadian phase shift and serotonergic hypotheses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Molecular mechanisms of the human circadian clock and retinal phototransduction of light
Number of subjects: 0
Study: 8866388

Group type: EXPERIMENTAL
Intervention: Routine management with daily telephone nursing contact (Group 2)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine management without daily telephone nursing contact (Control Group 1)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Overall management for all groups
Number of subjects: 64
Study: 1335006

Group type: EXPERIMENTAL
Intervention: Smaller cuff (mean decrease in CW: AC ratio: 7.4%)
Number of subjects: 1582

Group type: EXPERIMENTAL
Intervention: Larger cuff (mean increase in CW: AC ratio: 10.2%)
Number of subjects: 1582

Group type: COMPARATOR
Intervention: Recommended cuff (CW: AC ratio approximately 40%)
Number of subjects: 1582
Study: 6373586

Group type: EXPERIMENTAL
Intervention: KCl supplementation (96 mEq/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Non-KCl supplementation
Number of subjects: 23
Study: 30075578

Group type: COMPARATOR
Intervention: 20 mg atorvastatin (conventional-dose), n=12
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 40-80 mg atorvastatin (intensive-dose), n=12
Number of subjects: 24
Study: 27471782

Group type: EXPERIMENTAL
Intervention: Physical activity intervention encouraging parents to engage in physical activities with their child, including prone-based play and reducing restrained time in car seats and strollers.
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 802
Study: 25023813

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 1212

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 1212
Study: 22992307

Group type: EXPERIMENTAL
Intervention: Protein pulse feeding (PD group, n=30), 72% of dietary protein (1.31 g/kg weight/d on average) consumed in one meal at noon.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Protein spread feeding (SD group, n=36), dietary protein spread over four daily meals.
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Protein pulse feeding (PD group, n=30).
Number of subjects: 66

Group type: COMPARATOR
Intervention: Protein spread feeding (SD group, n=36).
Number of subjects: 66
Study: 20602502

Group type: EXPERIMENTAL
Intervention: Elective EVAR
Number of subjects: 756
Study: 17692577

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Bedtime NPH insulin
Number of subjects: 19
Study: 16821426

Group type: EXPERIMENTAL
Intervention: Atenolol (up to 50 mg daily)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Midodrine (up to 15 mg daily)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Combination of atenolol and midodrine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Atenolol, Midodrine, and their combination
Number of subjects: 35
Study: 15228175

Group type: EXPERIMENTAL
Intervention: Standard Parent-Child Interaction Therapy (STD)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Abbreviated Parent-Child Interaction Therapy (ABB)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No-treatment waitlist control group (WL)
Number of subjects: 54
Study: 11508685

Group type: EXPERIMENTAL
Intervention: Aboral pouch
Number of subjects: 40

Group type: COMPARATOR
Intervention: Simple Roux-en-Y reconstruction
Number of subjects: 40
Study: 9282240

Group type: EXPERIMENTAL
Intervention: Turbine spirometer (TS)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Bell spirometer (BS)
Number of subjects: 275
Study: 7962933

Group type: EXPERIMENTAL
Intervention: Modified buried vertical mattress suture technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional bi-layered closure technique
Number of subjects: 100
Study: 2852792

Group type: EXPERIMENTAL
Intervention: Rhesus rotavirus vaccine (MMU-18006)
Number of subjects: 40
Study: 29744871

Group type: EXPERIMENTAL
Intervention: Greater occipital nerve (GON) blockade with bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) dexketoprofen and metoclopramide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (normal saline injection into the GON area)
Number of subjects: 60
Study: 26899880

Group type: EXPERIMENTAL
Intervention: Unconditional Cash Transfers (UCT)
Number of subjects: 4043

Group type: EXPERIMENTAL
Intervention: Conditional Cash Transfers (CCT)
Number of subjects: 4043

Group type: COMPARATOR
Intervention: Control
Number of subjects: 4043
Study: 24283391

Group type: EXPERIMENTAL
Intervention: TENS (Group 2)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: TENS (Group 4)
Number of subjects: 200
Study: 22257443

Group type: EXPERIMENTAL
Intervention: Polite yawning technique (PYT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (non-laryngectomised patients)
Number of subjects: 200
Study: 20042446

Group type: EXPERIMENTAL
Intervention: 5 mg morphine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 54
Study: 18657945

Group type: EXPERIMENTAL
Intervention: 12-session manual-guided spiritual guidance (SG) intervention during and after inpatient treatment
Number of subjects: 140

Group type: COMPARATOR
Intervention: Spiritual direction (SG)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 140
Study: 15945557

Group type: EXPERIMENTAL
Intervention: Yoga intervention (4-week program including postures and breath work)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Stretching control condition
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 62
Study: 12567365

Group type: EXPERIMENTAL
Intervention: Noncontact normothermic wound therapy (Warm‐UP; Augustine Medical Inc.) applied for 1 hour 3 times daily until healing or 12 weeks.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care (saline‐moistened gauze applied once a day).
Number of subjects: 20
Study: 10551582

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg rapacuronium
Number of subjects: 336

Group type: COMPARATOR
Intervention: 1.0 mg/kg succinylcholine
Number of subjects: 336
Study: 8546143

Group type: EXPERIMENTAL
Intervention: PD Plus
Number of subjects: 7

Group type: COMPARATOR
Intervention: CAPD
Number of subjects: 7
Study: 1858703

Group type: EXPERIMENTAL
Intervention: 20 mg valine.kg body wt‐1.d‐1 with 80 mg leucine.kg‐1.d‐1
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10 mg valine.kg body wt‐1.d‐1 with 40 mg leucine.kg‐1.d‐1
Number of subjects: 6

Group type: COMPARATOR
Intervention: 10 mg valine.kg‐1.d‐1
Number of subjects: 6
Study: 6863097

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg/day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metoprolol (7 mg)
Number of subjects: 12
Study: 29053410

Group type: EXPERIMENTAL
Intervention: Low-dose exercise (8 kcal/kg of body weight per week)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: High-dose exercise (14 kcal/kg of body weight per week)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (both doses)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Higher VO2peak levels at baseline
Number of subjects: 49
Study: 29553096

Group type: EXPERIMENTAL
Intervention: Spontaneous respiration (SP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controlled ventilation with muscle relaxants (MR)
Number of subjects: 0
Study: 26598423

Group type: EXPERIMENTAL
Intervention: Tolvaptan 45 mg per day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 26562086

Group type: EXPERIMENTAL
Intervention: Psychoanalytic Child Therapy (PaCT); approximately 20 psychotherapy sessions in various settings (parent-child, child-alone, parent-alone).
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waitlist control group (no intervention during the waitlist period).
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Parent, child, and teacher reports.
Number of subjects: 30
Study: 22297706

Group type: EXPERIMENTAL
Intervention: Alternative model of birth (AMB)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Traditional model of birth (TMB)
Number of subjects: 199
Study: 19671217

Group type: EXPERIMENTAL
Intervention: tDCS (1 mA current strength, five treatment sessions, active or sham, given on alternate days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study: 18606420

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg daily for 14 days
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily for 14 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Aspirin 75 mg daily for 14 days (in CHD patients)
Number of subjects: 36
Study: 15692973

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study: 11994884

Group type: EXPERIMENTAL
Intervention: Intensive case management
Number of subjects: 43

Group type: COMPARATOR
Intervention: Comparison group (no case management)
Number of subjects: 43
Study: 10509953

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients with ascites
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients
Number of subjects: 98
Study: 7852133

Group type: EXPERIMENTAL
Intervention: Pilocarpine 2.5 mg, 5.0 mg, and 10.0 mg tablets three times a day for 12 weeks (dose-titration study)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Pilocarpine 5.0 mg and 10.0 mg tablets three times a day for 12 weeks (fixed-dose study)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo (fixed-dose study)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Pilocarpine (all dosages)
Number of subjects: 369
Study: 1777377

Group type: EXPERIMENTAL
Intervention: Quinapril (20 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 6743640

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate (LC) diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified-fat (MF) diet
Number of subjects: 0
Study: 30060149

Group type: EXPERIMENTAL
Intervention: Leader Adolescents in Transcultural Health Education (LATES) Project
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 30405296

Group type: EXPERIMENTAL
Intervention: Impaired homocysteine metabolism group (IHM, n=30)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal homocysteine metabolism group (NHM, n=10)
Number of subjects: 40
Study: 26953629

Group type: EXPERIMENTAL
Intervention: LCPT (once-daily extended-release tacrolimus tablets)
Number of subjects: 861

Group type: COMPARATOR
Intervention: Tac BID (twice-daily tacrolimus capsules)
Number of subjects: 861

Group type: EXPERIMENTAL
Intervention: LCPT
Number of subjects: 861

Group type: COMPARATOR
Intervention: Tac BID
Number of subjects: 861
Study: 24300782

Group type: EXPERIMENTAL
Intervention: Somatropin (0.03 mg/kg/day)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 23302453

Group type: EXPERIMENTAL
Intervention: Fast track surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 70
Study: 20226447

Group type: EXPERIMENTAL
Intervention: Luteal support with micronized progesterone (group IIb)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Luteal support with progesterone plus 17β-estradiol (group IIc)
Number of subjects: 9

Group type: COMPARATOR
Intervention: No luteal phase support (group IIa)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Endometrial biopsies on the day of oocyte retrieval (group I)
Number of subjects: 9
Study: 21512661

Group type: EXPERIMENTAL
Intervention: (131)I treatment
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Thyroid volume
Number of subjects: 156
Study: 16191752

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bupropion SR
Number of subjects: 36
Study: 12030955

Group type: EXPERIMENTAL
Intervention: Essential fatty acids (gamma-linolenic acid 1.6 g, eicosapentaenoic acid 270 mg, docosahexaenoic acid 45 mg per day)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (sunflower oil 500 mg/day)
Number of subjects: 63
Study: 9570606

Group type: EXPERIMENTAL
Intervention: 0.5% tetracaine in 0.75% glucose with 0.125% phenylephrine at the L2‐L3 interspace
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.5% tetracaine in 0.75% glucose with 0.125% phenylephrine at the L3‐L4 interspace
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.5% tetracaine in 7.5% glucose with 0.125% phenylephrine at the L3‐L4 interspace
Number of subjects: 120
Study: 8041539

Group type: EXPERIMENTAL
Intervention: Acupressure at PC‐6 point
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham control (placebo point)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Acupressure and Sham)
Number of subjects: 60
Study: 3051788

Group type: EXPERIMENTAL
Intervention: Selective proximal vagotomy with pyloroplasty
Number of subjects: 78

Group type: COMPARATOR
Intervention: Selective proximal vagotomy without pyloroplasty
Number of subjects: 78
Study: 31884877

Group type: EXPERIMENTAL
Intervention: Functional, mature arteriovenous fistulas (Group M)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Functional, non-mature arteriovenous fistulas (Group N)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Overall results for both groups
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Baseline diameter of cephalic vein
Number of subjects: 52
Study: 29923478

Group type: EXPERIMENTAL
Intervention: Weekly 8-session worry intervention group (n = 7)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Wait-list control (n = 6)
Number of subjects: 13
Study: 27517654

Group type: EXPERIMENTAL
Intervention: Prasugrel (20mg loading dose, followed by 5mg maintenance dose daily)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Clopidogrel (300mg loading dose, followed by 75mg maintenance dose daily)
Number of subjects: 76
Study: 25703448

Group type: EXPERIMENTAL
Intervention: Home-exercise program
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Home-exercise program (subgroup analysis)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 340
Study: 24386859

Group type: COMPARATOR
Intervention: Control group (prepuce of phimosis children and urethra of penile carcinoma patients)
Number of subjects: 50
Study: 19802508

Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL) 5 mg
Number of subjects: 233
Study: 18156455

Group type: EXPERIMENTAL
Intervention: High-flux membrane A (specific composition not detailed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-flux membrane B (specific composition not detailed)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-flux membrane A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-flux membrane B
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-flux membranes (general)
Number of subjects: 0
Study: 15716709

Group type: EXPERIMENTAL
Intervention: Acute pressor therapy (initiated ≤ 12 hours from stroke onset)
Number of subjects: 2050

Group type: EXPERIMENTAL
Intervention: Depressor therapy (started ≤ 24 hours post-ictus)
Number of subjects: 2050

Group type: EXPERIMENTAL
Intervention: Therapy (both pressor and depressor)
Number of subjects: 2050
Study: 12949357

Group type: EXPERIMENTAL
Intervention: 10 different foods with the same glycemic load as one slice of white bread
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stepwise increases in glycemic load (one, two, three, four, and six slices of bread)
Number of subjects: 10
Study: 10733109

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation (stimulator turned on)
Number of subjects: 2

Group type: COMPARATOR
Intervention: No stimulation (stimulator turned off)
Number of subjects: 2
Study: 9275461

Group type: EXPERIMENTAL
Intervention: 10mg mifepristone daily
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 20mg mifepristone daily
Number of subjects: 43